GL1X · GenesisL1 explorer

Research workbench

Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes

Analyse Cryo-EM structure of human immunoproteasome with a novel noncompetitive… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AVO
Type
protein
Length
6,192 residues
Chains
28
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proteasome subunit beta type-9; Proteasome subunit beta type-10; Proteasome subunit beta…
EC
3.4.25.1
UniProt
P28065, P40306, P28062, P25786, P28066, O14818, P25788, P60900, P25789, P25787, P20618, P49721, P49720, P28070
Ligands
BZ7
Pockets
20 · best druggability 0.80

Structure

electron microscopy · 14 distinct chains · 34% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, FProteasome subunit beta type-9 (EC 3.4.25.1)protein19934% helix, 25% strandP28065
B, EProteasome subunit beta type-10 (EC 3.4.25.1)protein21930% helix, 26% strandP40306
C, DProteasome subunit beta type-8 (EC 3.4.25.1)protein20135% helix, 29% strandP28062
G, LProteasome subunit alpha type-1 (EC 3.4.25.1)protein23431% helix, 24% strandP25786
H, MProteasome subunit alpha type-5 (EC 3.4.25.1)protein23332% helix, 23% strandP28066
I, NProteasome subunit alpha type-7 (EC 3.4.25.1)protein23237% helix, 22% strandO14818
J, QProteasome subunit alpha type-3 (EC 3.4.25.1)protein23936% helix, 23% strandP25788
K, RProteasome subunit alpha type-6 (EC 3.4.25.1)protein24034% helix, 23% strandP60900
O, ZProteasome subunit alpha type-4 (EC 3.4.25.1)protein24036% helix, 24% strandP25789
P, bProteasome subunit alpha type-2 (EC 3.4.25.1)protein23035% helix, 22% strandP25787
S, XProteasome subunit beta type-1 (EC 3.4.25.1)protein21331% helix, 29% strandP20618
T, VProteasome subunit beta type-2 (EC 3.4.25.1)protein19633% helix, 32% strandP49721
U, YProteasome subunit beta type-3 (EC 3.4.25.1)protein20432% helix, 26% strandP49720
W, aProteasome subunit beta type-4 (EC 3.4.25.1)protein21634% helix, 30% strandP28070

Ligands and binding sites

  • BZ7 · N~1~-{2-[([1,1'-biphenyl]-3-carbonyl)amino]ethyl}-N~4~-tert-butyl-N~2~-(3-phenylpropanoyl)-L-aspartamide · ligand · 2 copies · chains C, X, D, S

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110730.800.81105empty
27310.800.8481empty
39240.790.8187empty
410410.790.81136BZ7
57420.790.8381empty

Interfaces

86 interfaces between chains.

  • N–O · 1505 Ų buried · 21 hydrogen bonds · protein-protein
  • I–Z · 1468 Ų buried · 20 hydrogen bonds · protein-protein
  • E–U · 1465 Ų buried · 21 hydrogen bonds · protein-protein
  • B–Y · 1457 Ų buried · 23 hydrogen bonds · protein-protein
  • Z–b · 1433 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6AVO · Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that… · the same entry in another collection · chain S against S, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.